Page 136 - 南京医科大学学报自然科学版

第43卷第3期
·426 · 南 京 医 科 大 学 学 报 2023年3月

ome，2020，8（1）：12 sions in Clostridium difficile infection［J］. J Gastroenterol
［26］ KOOTTE R S，LEVIN E，SALOJÄRVI J，et al. Improve⁃ Hepatol，2020，35（11）：1909-1915
ment of insulin sensitivity after lean donor feces in meta⁃ ［38］ SOKOL H. Antibiotics：a trigger for inflammatory bowel
bolic syndrome is driven by baseline intestinal Microbiota disease?［J］. Lancet Gastroenterol Hepatol，2020，5（11）：
composition［J］. Cell Metab，2017，26（4）：611-619 956-957
［27］ LEONARDI I，PARAMSOTHY S，DORON I，et al. Fun⁃ ［39］ KESHTELI A H，MILLAN B，MADSEN K L. Pretreat⁃
gal trans⁃Kingdom dynamics linked to responsiveness to ment with antibiotics may enhance the efficacy of fecal
fecal Microbiota transplantation（FMT）therapy in ulcer⁃ microbiota transplantation in ulcerative colitis：a meta ⁃
ative colitis［J］. Cell Host Microbe，2020，27（5）：823-829 analysis［J］. Mucosal Immunol，2017，10（2）：565-566
［28］ GOGOKHIA L，BUHRKE K，BELL R，et al. Expansion of ［40］ ISHIKAWA D，SASAKI T，OSADA T，et al. Changes in
bacteriophages is linked to aggravated intestinal inflam⁃ intestinal Microbiota following combination therapy with
mation and colitis［J］. Cell Host Microbe，2019，25（2）： fecal microbial transplantation and antibiotics for ulcera⁃
285-299 tive colitis［J］. Inflamm Bowel Dis，2017，23（1）：116-125
［29］ DAVID L A，MAURICE C F，CARMODY R N，et al. Diet ［41］ LE ROY T，DEBÉDAT J，MARQUET F，et al. Compara⁃
rapidly and reproducibly alters the human gut microbiome tive evaluation of Microbiota engraftment following fecal
［J］. Nature，2014，505（7484）：559-563 Microbiota transfer in mice models：age，kinetic and mi⁃
［30］ WEI Y，GONG J，ZHU W，et al. Pectin enhances the crobial status matter［J］. Front Microbiol，2018，9：3289
effect of fecal microbiota transplantation in ulcerative coli⁃ ［42］ JI S K，YAN H，JIANG T，et al. Preparing the gut with anti⁃
tis by delaying the loss of diversity of gut flora［J］. BMC biotics enhances gut Microbiota reprogramming efficiency
Microbiol，2016，16（1）：255 by promoting xenomicrobiota colonization［J］. Front Mi⁃
［31］ MOCANU V，ZHANG Z，DEEHAN E C，et al. Fecal mi⁃ crobiol，2017，8：1208
crobial transplantation and fiber supplementation in pa⁃ ［43］ ALLEGRETTI JR，KAO D，SITKO J，et al. Early antibiotic
tients with severe obesity and metabolic syndrome：a ran⁃ use after fecal microbiota transplantation increases risk of
domized double ⁃ blind，placebo ⁃ controlled phase 2 trial treatment failure［J］. Clin Infect Dis，2018，66（1）：134-135
［J］. Nat Med，2021，27（7）：1272-1279 ［44］ GWEON T G，LEE Y J，KIM K O，et al. Clinical practice
［32］ RINOTT E，YOUNGSTER I，YASKOLKA MEIR A，et al. guidelines for fecal Microbiota transplantation in Korea
Effects of diet ⁃ modulated autologous fecal Microbiota ［J］. J Neurogastroenterol Motil，2022，28（1）：28-42
transplantation on weight regain［J］. Gastroenterology， ［45］ ZHERNAKOVA A，KURILSHIKOV A，BONDER M J，et
2021，160（1）：158-173 al. Population⁃based metagenomics analysis reveals mar⁃
［33］ NG S C，XU Z，MAK J W Y，et al. Microbiota engraftment kers for gut microbiome composition and diversity［J］.
after faecal Microbiota transplantation in obese subjects Science，2016，352（6285）：565-569
with type 2 diabetes：a 24 ⁃ week，double ⁃ blind，ran⁃ ［46］ MULLISH B H，QURAISHI M N，SEGAL J P，et al. The
domised controlled trial［J］. Gut，2022，71（4）：716-723 use of faecal microbiota transplant as treatment for recur⁃
［34］ IANIRO G，VALERIO L，MASUCCI L，et al. Predictors of rent or refractory Clostridium difficile infection and other
failure after single faecal microbiota transplantation in pa⁃ potential indications：joint British Society of Gastroen ⁃
tients with recurrent Clostridium difficile infection：results terology（BSG）and Healthcare Infection Society（HIS）
from a three⁃year，single⁃centre cohort study［J］. Clin Mi⁃ guidelines［J］. Gut，2018，67（11）：1920-1941
crobiol Infect，2016，23（5）：337-337 ［47］ IMHANN F，BONDER M J，VICH VILA A，et al. Proton
［35］ FISCHER M，KAO D，MEHTA S R，et al. Predictors of pump inhibitors affect the gut microbiome［J］. Gut，2016，
early failure after fecal Microbiota transplantation for the 65（5）：740-748
therapy of Clostridium difficile infection：a multicenter ［48］ LIU W，LUO Z，ZHOU J，et al. Gut Microbiota and anti⁃
study［J］. Am J Gastroenterol，2016，111（7）：1024-1031 diabetic drugs：perspectives of personalized treatment in
［36］ BERAN A，SHARMA S，GHAZALEH S，et al. Predictors type 2 diabetes mellitus［J］. Front Cell Infect Microbiol，
of fecal microbiota transplant failure in clostridioides diffi⁃ 2022，12：853771
cile infection：an updated meta ⁃ analysis［J/OL］. J Clin ［49］ WEERSMA R K，ZHERNAKOVA A，FU J Y. Interaction
Gastroenterol，2022［2022 ⁃ 01 ⁃ 20］. doi：10.1097/ between drugs and the gut microbiome［J］. Gut，2020，69
MCG.0000000000001667 （8）：1510-1519
［37］ GALLO A，CANCELLI C，CERON E，et al. Fecal calpro⁃ ［50］ LI P，ZHANG T，XIAO Y，et al. Timing for the second
tectin and need of multiple microbiota trasplantation infu⁃ （下转第437页）